Showing results (11-20 of 1,063) with videos related to
Sort By:
Pageof 107
Biotechnology and Bioengineering|March 20, 1996
The application of membrane biological reactors for the treatment of wastewatersK Brindle, T StephensonWater Science and Technology : a Journal of the International Association on Water Pollution Research|February 3, 2004
Cost-effective treatment solutions for rural areas: design and operation of a new package treatment plant for single householdsD Daude, T StephensonWater Science and Technology : a Journal of the International Association on Water Pollution Research|February 3, 2004
Moving bed biofilm reactors: a small-scale treatment solutionD Daude, T StephensonArchives of Disease in Childhood. Fetal and Neonatal Edition|November 7, 2003
Neonatal transfers by advanced neonatal nurse practitioners and paediatric registrarsA Leslie, T StephensonJournal of Medicinal Chemistry|September 1, 1989
New anticancer agents: chiral isomers of ethyl 5-amino-1,2-dihydro-2-methyl-3-phenylpyrido[3,4-b]pyrazine-7-car bamateC Temple, G A RenerHealth Matrix|December 5, 1989
The Philadelphia Health Insurance Organization: the results of managed health care for 96,000 medical assistance recipientsP C Temple, S KronJournal of Medicinal Chemistry|January 4, 1993
Antimitotic agents: ring analogues and derivatives of ethyl [(S)-5-amino-1,2-dihydro-2-methyl-3-phenylpyrido[3,4-b]pyrazin-7- yl]carbamateC Temple, G A RenerJournal of Medicinal Chemistry|March 30, 1992
Antimitotic agents. Chiral isomers of ethyl [5-amino-1,2-dihydro-3-(4-hydroxyphenyl)-2-methylpyrido[3,4-b]pyrazin-7 -yl]carbamateC Temple, G A RenerJournal of Medicinal Chemistry|November 1, 1990
Potential antimitotic agents. Synthesis of some ethyl benzopyrazin-7-ylcarbamates, ethyl pyrido[3,4-b]pyrazin-7-ylcarbamates, and ethyl pyrido[3,4-e]-as-triazin-7-ylcarbamatesC Temple, G A RenerPublic Health Reviews|May 18, 1999
Fear, threat, and perceptions of efficacy from frightening skin cancer messagesM T Stephenson, K WittePageof 107